AP
Apnimed, Inc.
APMD · NASDAQ
$26.22 -8.75% (-$2.52)
1M +2.30%
Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 0.00x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na APMD
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Kevin R. Lind
Employees
65
Headquarters
Cambridge